GLP-1 Weight Loss in Washington (2026)
14 GLP-1 telehealth providers ship to Washington, District of Columbia. Compounded semaglutide averages $199/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
About GLP-1 Access in Washington
Washington is a major city in the United States, located in District of Columbia with a population of approximately 712,816. Telehealth is legal in District of Columbia, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Washington ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.
District of Columbia's adult obesity rate is approximately 24.7% based on CDC Behavioral Risk Factor Surveillance System data[2], and state rankings are published in CDC's Adult Obesity Facts[3].
Browse by Medication
GLP-1 Providers Serving Washington
Vytora Health
Best for: Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
Editorial score · methodology
LillyDirect Foundayo
Best for: patients with commercial insurance who want the cheapest legal brand-name GLP-1
Editorial score · methodology
Elara Health and Wellness
Best for: Patients seeking a physician-guided bundled-care GLP-1 program (medication + quarterly labs + physician visits + coaching + 24/7 messaging at a single monthly price) with maximum pharmacy-partner transparency (four named 503A pharmacies disclosed) and clear corporate accountability (JTE Medical, LLC named parent). Strong fit for buyers who want more than transactional Rx access but don't need the unlimited-primary-care scope of true DPC models.
Editorial score · methodology
Fresh Day Meds
Best for: Price-sensitive patients seeking the lowest-cost compounded semaglutide or tirzepatide from a LegitScript-certified, HIPAA-compliant multi-product telehealth platform with publicly disclosed Texas corporate headquarters, who don't require a named pharmacy partner or brand-name GLP-1 fallback.
Editorial score · methodology
Primary Clinic (Direct GLP)
Best for: Patients in the 10 covered states who want GLP-1 medications as part of a continuous Direct Primary Care relationship (including labs, routine meds, unlimited visits, and ongoing provider monitoring) rather than a transactional DTC marketplace purchase, and who calculate the $89/mo membership fee plus wholesale med cost is favorable vs $300-$500/mo all-in DTC pricing.
Editorial score · methodology
NP2GO
Best for: Cost-sensitive patients in any of the 39 supported states + DC who want transparent per-dose pricing with the flexibility to choose Pay As You Go or Month-to-Month Membership. Particularly suited for Oklahoma residents who can access the in-person Edmond office + the additional Oklahoma-only services on one platform.
Editorial score · methodology
Editorial score · methodology
Gimme Care
Best for: affordable compounded GLP-1 with nationwide coverage and microdose options
Editorial score · methodology
Ondra Health
Best for: Cost-sensitive patients who want the lowest compounded-GLP-1 monthly cost and are willing to commit quarterly.
Editorial score · methodology
Care Clinics
Best for: Cost-sensitive patients in one of the 32 listed states who want a LegitScript-certified telehealth clinic with multi-duration program options (from 4-week trials to 3-month commitments to extended plans) and a named PLLC corporate entity for accountability.
Editorial score · methodology
Editorial score · methodology
Gatlan
Best for: Buyers seeking a named-clinical-leadership GLP-1 platform with Dr. Robert Lufkin (UCLA/USC) as Chief Medical Advisor, who value verifiable academic credentials over anonymous DTC marketplace framing, and who live in one of the 44 covered states. Strong fit for premium-clinical-attention buyers who are comfortable with pricing gated behind sign-up.
Editorial score · methodology
Get StartedRead full Gatlan review →InstaRX
Best for: Patients in any of the 50 states or DC seeking a multi-product compounded-medication telehealth platform (GLP-1 + peptides + sexual health) where they prefer to complete an intake to see pricing rather than comparing public per-dose tiers. NOT recommended for patients who require transparent upfront pricing, named pharmacy-partner disclosure, or visible LegitScript/HIPAA accreditation before committing to an intake.
Editorial score · methodology
In-Person vs Telehealth in Washington
Patients in Washington have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to District of Columbia addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in District of Columbia varies by plan[4].
Cost of GLP-1 Medications in Washington
Brand-name Wegovy in Washington typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $$199/month in District of Columbia, representing savings of more than $13,000 per year.
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Get Washington Price Alerts
Be the first to know about new GLP-1 providers and price changes in Washington.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
- 3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
- 4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.